Leaflet PABAL 100mcg / ml solution for injection


Indicated for: uterine contractions; postpartum hemorrhage

Route of administration: injectable

Substance: carbetocin (uterotonic)

ATC: H01BB03 (Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Oxytocin and analogues)

Carbetocin is a synthetic analog of oxytocin used to prevent postpartum hemorrhage caused by uterine atony. It is a uterotonic that stimulates uterine contractions and is typically administered after cesarean or vaginal delivery.

Carbetocin is effective in reducing postpartum blood loss and is considered a safe and efficient alternative to oxytocin. Unlike oxytocin, it has a longer duration of action, reducing the need for repeated administration.

It is well-tolerated but may cause side effects such as nausea, vomiting, headache, or low blood pressure. Its use is contraindicated during active pregnancy or in cases of hypersensitivity to the substance.

General data about PABAL 100mcg / ml

  • Substance: carbetocin
  • Date of last drug list: 01-09-2024
  • Commercial code: W61784001
  • Concentration: 100mcg / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 5
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: FERRING GMBH - GERMANIA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 521/2020/01
  • Shelf life: 2 years